Predictors of shoulder limitations and disability in patients with cardiac implantable electronic devices: Importance of device size


COŞGUN M. S., Cosgun C.

PACE - Pacing and Clinical Electrophysiology, cilt.44, sa.12, ss.1979-1986, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 12
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1111/pace.14378
  • Dergi Adı: PACE - Pacing and Clinical Electrophysiology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, SportDiscus
  • Sayfa Sayıları: ss.1979-1986
  • Anahtar Kelimeler: cardiac implantable electronic device, defibrillator, device size, pacemaker, shoulder disabilities, CARDIOVERTER-DEFIBRILLATOR, ESC GUIDELINES, COMPLICATIONS, MANAGEMENT, QUICKDASH, PACEMAKER, MOTION
  • Gazi Üniversitesi Adresli: Hayır

Özet

© 2021 Wiley Periodicals LLCBackground: Generator-induced shoulder impairment is a common complication of cardiac implantable electronic device (CIED) implantation. Although implantable cardioverter–defibrillators (ICDs) have become smaller in size, they are still bigger than pacemakers (PMs). This study aimed to investigate the effects of single-chamber PM and ICD sizes on shoulder function. Methods: This retrospective study included 200 consecutive patients, of whom 123 had PMs and 77 had ICDs. The CIED implantation effects on shoulder function, pain, disability, and quality of life (QoL) were evaluated. The range of motion (ROM), Visual Analog Scale (VAS), Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH), and Short Form-36 (SF-36) Health Survey (Physical and Mental Component Summary [PCS and MCS]) were used. Results: The flexion and abduction range limitation rates were significantly higher in the ICD group than in the PM group (16.9% vs. 7.3%, p =.035 and 19.5% vs. 8.9%, p =.031, respectively). The two groups had similar VAS scores. The median QuickDASH score was significantly higher in the ICD group than in the PM group (8.2 [3.6–19.6] vs. 4.6 [2.6–17.9], p =.034). There were no significant differences in SF-36 components between the two groups. ICD implantation (OR: 1.642, 95% CI: 1.293–2.776; p =.001) and incision length (OR: 1.343, 95% CI: 1.194–2.064; p =.01) were independent predictors of shoulder ROM limitations. Conclusions: Reduced device sizes with advancing technology can decrease shoulder functional limitations and disability after implantation. Healthcare professionals should not neglect shoulder evaluations during the pre- and postimplantation periods.